Inventor · disambiguated record
Ulf Grawunder
Also filed as: GRAWUNDER ULF
22 granted patents·8 pending applications·126 citations·filing 2001–2022
95Inventor score
Top patents by PatentIndex Score
30 records- 0197US11364301B2Method of producing an immunoligand/payload conjugateNBE THERAPEUTICS AG·Filed 2020·Granted Jun 21, 2022·6 cites·20 claims
- 0296US11242388B2ROR1 antibody compositions and related methodsNBE THERAPEUTICS AG·Filed 2020·Granted Feb 8, 2022·8 cites·12 claims
- 0396US10864277B2Method of producing an immunoligand/payload conjugateNBE THERAPEUTICS AG·Filed 2017·Granted Dec 15, 2020·13 cites·36 claims
- 0494US10960083B2Binding protein drug conjugates comprising anthracycline derivativesNBE THERAPEUTICS AG·Filed 2019·Granted Mar 30, 2021·6 cites·13 claims
- 0593US10618959B2ROR1 antibody compositions and related methodsNBE THERAPEUTICS AG·Filed 2018·Granted Apr 14, 2020·11 cites·26 claims
- 0693US9872923B2Method of producing an immunoligand/payload conjugateNBE THERAPEUTICS AG·Filed 2014·Granted Jan 23, 2018·19 cites·14 claims
- 0789US10758556B2Anthracycline-based antibody drug conjugates having high in vivo tolerabilityNBE THERAPEUTICS AG·Filed 2019·Granted Sep 1, 2020·8 cites·31 claims
- 0885US10517959B2Binding protein drug conjugates comprising anthracycline derivativesNBE THERAPEUTICS AG·Filed 2018·Granted Dec 31, 2019·3 cites·8 claims
- 0985US10188745B2Binding protein drug conjugates comprising anthracycline derivativesNBE THERAPEUTICS AG·Filed 2015·Granted Jan 29, 2019·4 cites·28 claims
- 1085US10174309B2Transposition-mediated identification of specific binding or functional proteinsNBE THERAPEUTICS LLC·Filed 2013·Granted Jan 8, 2019·9 cites·7 claims
- 1185US7741077B2Method for the generation of genetically modified vertebrate precursor lymphocytes and use thereof for the production of heterologous binding proteins4ANTIBODY AG·Filed 2001·Granted Jun 22, 2010·31 cites·25 claims
- 1282US11447546B2Human antibodies binding to ROR2NBE THERAPEUTICS AG·Filed 2018·Granted Sep 20, 2022·2 cites·5 claims
- 1380US11986535B2Method of producing an immunoligand/payload conjugateNBE THERAPEUTICS AG·Filed 2022·Granted May 21, 2024·0 cites·23 claims
- 1474US11833120B2Binding protein drug conjugates comprising anthracycline derivativesNBE THERAPEUTICS AG·Filed 2021·Granted Dec 5, 2023·0 cites·18 claims
- 1573US8748353B2Identification of antigen or ligand-specific binding proteinsGRAWUNDER ULF·Filed 2009·Granted Jun 10, 2014·1 cites·18 claims
- 1673US8716194B2Identification of antigen or ligand-specific binding proteinsGRAWUNDER ULF·Filed 2011·Granted May 6, 2014·1 cites·14 claims
- 1770US2022153839A1Ror1 antibody compositions and related methodsNBE THERAPEUTICS AG·Filed 2021·Application pending·0 cites
- 1869US9593327B2Identification of antigen or ligand-specific binding proteins4-ANTIBODY AG·Filed 2014·Granted Mar 14, 2017·1 cites·30 claims
- 1966US12275789B2Human antibodies binding to ROR2NBE THERAPEUTICS AG·Filed 2022·Granted Apr 15, 2025·0 cites·9 claims
- 2066US9346874B2Binding members for human cytomegalovirusGRAWUNDER ULF·Filed 2012·Granted May 24, 2016·3 cites·25 claims
- 2163US10502745B2Identification of antigen- or ligand-specific binding proteinsAGENUS INC·Filed 2017·Granted Dec 10, 2019·0 cites·18 claims
- 2258US12121527B2Anthracycline-based antibody drug conjugates having high in vivo tolerabilityNBE THERAPEUTICS AG·Filed 2020·Granted Oct 22, 2024·0 cites·19 claims
- 2357US2011059056A1Method for the Generation of Genetically Modified Vertebrate Precursor Lymphocytes and Use Thereof for the Production of Heterologous Binding Proteins4ANTIBODY AG·Filed 2009·Application pending·0 cites
- 2453US2019153433A1Transposition-mediated identification of specific binding or functional proteinsNBE THERAPEUTICS LLC·Filed 2018·Application pending·0 cites
- 2551US2021379194A1Binding protein-toxin conjugates comprising anthracyclines, and use thereof in immune-oncological applicationsNBE THERAPEUTICS AG·Filed 2019·Application pending·0 cites
- 2648US2024158435A1Biocatalytical composition and use for generation of immunoligand-payload conjugatesINOFEA AG·Filed 2022·Application pending·0 cites
- 2747US2021139579A1Multispecific antibody product that binds to different ror1 epitopesNBE THERAPEUTICS AG·Filed 2018·Application pending·0 cites
- 2844US11845793B2Anti-ROR1 antibodiesNBE THERAPEUTICS AG·Filed 2016·Granted Dec 19, 2023·0 cites·8 claims
- 2936US2018028682A1Maytansine-drug conjugates of her-2 specific binding proteins generated by site specific sortase-enzyme mediated conjugationNBE THERAPEUTICS AG·Filed 2016·Application pending·0 cites
- 3036US2019112385A1Anti-mesothelin antibodiesNBE THERAPEUTICS AG·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Ulf Grawunder files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →